These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 954353

  • 21. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
    McCaul ME, Wand GS, Rohde C, Lee SM.
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
    [Abstract] [Full Text] [Related]

  • 22. Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk.
    Chan CF, Page-Sharp M, Kristensen JH, O'Neil G, Ilett KF.
    J Hum Lact; 2004 Aug; 20(3):322-6. PubMed ID: 15296587
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Pharmacokinetics of 6beta-naltrexol after single and multiple intramuscular injections in Beagle dogs].
    Yan LD, Liu J, Dong HJ, Cui MX, Yao XJ, Liu YS, Gong ZH, Gong ZH.
    Yao Xue Xue Bao; 2009 Jul; 44(7):722-5. PubMed ID: 19806909
    [Abstract] [Full Text] [Related]

  • 27. Serum time course of naltrexone and 6 beta-naltrexol levels during long-term treatment in drug addicts.
    Ferrari A, Bertolotti M, Dell'Utri A, Avico U, Sternieri E.
    Drug Alcohol Depend; 1998 Nov 01; 52(3):211-20. PubMed ID: 9839147
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The stimulatory effect of morphine on reduction of naltrexone to 6 alpha-naltrexol in the guinea pig.
    Roerig SC, Fujimoto JM, Wang RI.
    Drug Metab Dispos; 1980 Nov 01; 8(5):295-9. PubMed ID: 6107224
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.
    Hulse GK, Arnold-Reed DE, O'Neil G, Chan CT, Hansson RC.
    Addict Biol; 2004 Mar 01; 9(1):67-72. PubMed ID: 15203441
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of morphine and its surrogates V: Naltrexone and naltrexone conjugate pharmacokinetics in the dog as a function of dose.
    Garrett ER, el-Koussi A el-D.
    J Pharm Sci; 1985 Jan 01; 74(1):50-6. PubMed ID: 3981418
    [Abstract] [Full Text] [Related]

  • 33. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone.
    Porter SJ, Somogyi AA, White JM.
    Addict Biol; 2002 Apr 01; 7(2):219-25. PubMed ID: 12006217
    [Abstract] [Full Text] [Related]

  • 34. Naltrexone metabolism and sustained release following administration of an insoluble complex to rhesus monkeys and guinea-pigs.
    Macgregor TR, Drum MA, Harrigan SE, Wiley JN, Reuning RH.
    J Pharm Pharmacol; 1983 Jan 01; 35(1):38-42. PubMed ID: 6131962
    [Abstract] [Full Text] [Related]

  • 35. Metabolic reduction of naltrexone II. In vitro studies using liver from guinea pig, monkey and rat.
    Malspeis L, Ludden TM, Bathala MS, Morrison BE, Feller DR, Reuning RH.
    Res Commun Chem Pathol Pharmacol; 1976 Jul 01; 14(3):393-406. PubMed ID: 822483
    [Abstract] [Full Text] [Related]

  • 36. Clinical evaluation of a naltrexone sustained-release preparation.
    Chiang CN, Hollister LE, Gillespie HK, Foltz RL.
    Drug Alcohol Depend; 1985 Sep 01; 16(1):1-8. PubMed ID: 4064907
    [Abstract] [Full Text] [Related]

  • 37. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K, Lamson M, Salageanu J, Bramson C, Matschke K, Malhotra B.
    Clin Pharmacol Drug Dev; 2015 Sep 01; 4(5):370-6. PubMed ID: 27137146
    [Abstract] [Full Text] [Related]

  • 38. Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.
    Misra AL, Bloch R, Vardy J, Mulé SJ, Verebely K.
    Drug Metab Dispos; 1976 Sep 01; 4(3):276-80. PubMed ID: 6233
    [Abstract] [Full Text] [Related]

  • 39. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM, Lowery JJ, Bhamidipati CM, Paolino RM, Blair JR, Wang D, Sadée W, Bilsky EJ.
    J Pharmacol Exp Ther; 2005 Jun 01; 313(3):1150-62. PubMed ID: 15716384
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.